Clowise-A

Clopidogrel 75 mg and Aspirin 75 mg is a fixed-dose combination of two established antiplatelet agents used in cardiovascular care. It is indicated for the prevention and management of atherothrombotic events, where platelet aggregation may contribute to complications such as myocardial infarction and ischemic stroke. By acting on different pathways involved in platelet activation, this combination helps reduce the likelihood of clot formation in appropriately selected patients.It's commonly prescribed in individuals with acute coronary syndrome (ACS), a history of myocardial infarction, or ischemic stroke. It is also used in patients undergoing percutaneous coronary intervention (PCI), including those with stent placement, to help lower the risk of thrombotic events. In certain clinical situations, it may be considered as part of long-term secondary prevention under medical supervision.

How does Clopidogrel + Aspirin work?

This combination provides dual antiplatelet activity through complementary mechanisms.Clopidogrel inhibits the P2Y12 receptor on platelets, thereby reducing ADP-mediated platelet activation and aggregation. Aspirin works by inhibiting cyclooxygenase-1 (COX-1), which leads to decreased production of thromboxane A2, a mediator involved in platelet aggregation and vasoconstriction.Through these combined actions, the therapy helps limit platelet aggregation and supports smoother blood flow, contributing to a reduction in clot-related cardiovascular risks.

Clinical Benefits of Clopidogrel 75 mg + Aspirin 75 mg

• Helps reduce the risk of myocardial infarction and ischemic stroke in high-risk patients
• Provides dual antiplatelet action through complementary pathways
• Commonly used in the management of acute coronary syndrome (ACS)
• Supports prevention of stent-related thrombotic complications following coronary interventions
• May be considered as part of long-term cardiovascular risk management
• Well-established combination in routine clinical practice
• Once-daily dosing supports ease of use and adherence
• Can be included in guideline-based therapy as advised by a healthcare professional

Dosage and Administration

Clopidogrel 75 mg + Aspirin 75 mg is administered orally, usually once daily, or as directed by a healthcare professional. The duration of therapy depends on the clinical indication and individual patient factors.The tablet should be swallowed whole with water and may be taken with or without food. Consistent daily administration is important to maintain the intended therapeutic effect. Patients should not discontinue therapy without consulting their physician, as interruption may increase the risk of thrombotic events.

Safety and Precautions

This combination should be used under appropriate medical supervision due to its effect on platelet function and the associated risk of bleeding. Patients should be monitored for signs and symptoms of bleeding during treatment.Caution is advised in individuals with a history of gastrointestinal bleeding, peptic ulcer disease, or bleeding disorders. Use in patients with hepatic or renal impairment requires careful consideration. The product is not recommended in individuals with active pathological bleeding.Concomitant use with anticoagulants, other antiplatelet agents, or nonsteroidal anti-inflammatory drugs (NSAIDs) may increase bleeding risk and should be evaluated carefully. Patients should inform their healthcare provider prior to any surgical or dental procedures, as temporary discontinuation may be required.

Storage Instructions

Store in a cool and dry place below 25°C. Protect from moisture and direct sunlight. Keep out of reach of children. Do not use after the expiry date mentioned on the packaging.

Disclaimer

This information is intended for healthcare professionals only. The product should be used under medical supervision. For complete prescribing details, please refer to the approved prescribing information before use.